France vs Jordan: Cancer death rates in children under 10 years old
France
1.64 deaths per 100,000 people
in 2022
Jordan
1.61 deaths per 100,000 people
in 2018
France rank
79th
Jordan rank
81st
Cancer death rates in children under 10 years old over time
- France
- Jordan
How they compare
France currently reports 1.64 deaths per 100,000 people against 1.61 deaths per 100,000 people in Jordan, a difference of 0.03 deaths per 100,000 people.
The two have swapped places 1 time across 9 shared years of data; in 2008 it was Jordan ahead.
France ranks 79th and Jordan ranks 81st of 110 countries.
Across the 2 decades both report, France averaged higher in 1 and Jordan in 1.
Head to head by decade
| Decade | France | Jordan | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 2.14 deaths per 100,000 people | 2.39 deaths per 100,000 people | 0.2446 deaths per 100,000 people | Jordan |
| 2010s | 1.91 deaths per 100,000 people | 1.5 deaths per 100,000 people | 0.4062 deaths per 100,000 people | France |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cancer death rates in children under 10 years old, France or Jordan?
- France, at 1.64 deaths per 100,000 people against 1.61 deaths per 100,000 people in Jordan as of 2022.
- What is the difference in cancer death rates in children under 10 years old between France and Jordan?
- 0.03 deaths per 100,000 people, with France ahead.
- How many years of comparable data are there for France and Jordan?
- 9 years are reported by both, from 2008 to 2018.
- How do France and Jordan rank globally for cancer death rates in children under 10 years old?
- France ranks 79th and Jordan ranks 81st of 110 countries.
- Where does this data come from?
- WHO Mortality Database (2025) – with minor processing by Our World in Data, published as Cancer death rates in children under 10 years old. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Reported deaths from malignant neoplasms per 100,000 people in both sexes aged 10-14 years.